Enliven Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option Exercise | 10,000 | $2.48 | $24,800 | 23,000 | Mar 4, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option Exercise | 3,250 | $2.48 | $8,060 | 16,250 | Feb 27, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 6,667 | $21.93 | $146,207 | 329,977 | Feb 7, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 1,000 | $22.52 | $22,520 | 13,000 | Feb 5, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option Exercise | 3,250 | $2.48 | $8,060 | 16,250 | Jan 27, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 90 | $24.60 | $2,214 | 336,644 | Jan 7, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 3,350 | $22.15 | $74,203 | — | Dec 27, 2024 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option Exercise | 1,000 | $2.48 | $2,480 | 14,000 | Dec 13, 2024 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 1,000 | $25.38 | $25,380 | — | Nov 27, 2024 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 5,600 | $28.49 | $159,544 | 650 | Oct 28, 2024 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 716 | $30.00 | $21,480 | 343,311 | Oct 18, 2024 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 847 | $30.00 | $25,410 | 1,015,188 | Oct 18, 2024 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 924 | $30.00 | $27,720 | 1,002,892 | Oct 18, 2024 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 814 | $30.00 | $24,420 | — | Oct 18, 2024 |
| Heyman Richard A. | — | Sale | 817 | $30.00 | $24,510 | 123,673 | Oct 18, 2024 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | Option Exercise | 816 | $2.48 | $2,024 | 816 | Oct 18, 2024 |
| Heyman Richard A. | — | Sale | 1,270 | $27.67 | $35,141 | 124,490 | Oct 15, 2024 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 13,167 | $27.96 | $368,149 | 1,054,013 | Oct 9, 2024 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 13,880 | $28.07 | $389,612 | 1,006,646 | Oct 8, 2024 |
| Ballal Rahul D. | — | Sale | 10,420 | $28.17 | $293,531 | 22,341 | Oct 8, 2024 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 1,270 | $27.51 | $34,938 | — | Oct 7, 2024 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 2,707 | $27.61 | $74,740 | 1,067,180 | Oct 4, 2024 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 2,730 | $27.50 | $75,075 | 1,033,793 | Oct 4, 2024 |
| Heyman Richard A. | — | Sale | 2,825 | $27.51 | $77,716 | 125,760 | Oct 4, 2024 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 527 | $27.54 | $14,514 | 1,077,409 | Oct 1, 2024 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 526 | $27.54 | $14,486 | 1,048,729 | Oct 1, 2024 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 521 | $27.54 | $14,348 | — | Oct 1, 2024 |
| Heyman Richard A. | — | Sale | 518 | $27.54 | $14,266 | 128,585 | Oct 1, 2024 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option Exercise | 4,250 | $2.48 | $10,540 | 4,250 | Sep 30, 2024 |
| Heyman Richard A. | — | Sale | 1,270 | $22.41 | $28,461 | 129,103 | Sep 16, 2024 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 50 | $23.08 | $1,154 | 1,077,936 | Aug 29, 2024 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option Exercise | 4,250 | $2.48 | $10,540 | 4,250 | Aug 27, 2024 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 12,000 | $22.89 | $274,680 | 1,049,255 | Aug 26, 2024 |
| Heyman Richard A. | — | Sale | 620 | $23.70 | $14,694 | 130,373 | Aug 15, 2024 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 3,099 | $27.56 | $85,408 | 1,089,936 | Jul 31, 2024 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 2,270 | $27.56 | $62,561 | 1,061,255 | Jul 31, 2024 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 991 | $27.53 | $27,282 | — | Jul 31, 2024 |
| Heyman Richard A. | — | Sale | 1,702 | $27.51 | $46,822 | 131,643 | Jul 31, 2024 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 203 | $27.43 | $5,568 | 1,093,035 | Jul 29, 2024 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option Exercise | 5,250 | $2.48 | $13,020 | 5,250 | Jul 29, 2024 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 43 | $25.83 | $1,111 | 1,063,525 | Jul 25, 2024 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 30,978 | $25.05 | $775,999 | 345,574 | Jul 16, 2024 |
| Heyman Richard A. | — | Sale | 1,270 | $24.80 | $31,496 | 133,345 | Jul 15, 2024 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 3,000 | $25.07 | $75,210 | — | Jul 12, 2024 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 12,000 | $22.89 | $274,680 | 1,105,035 | Jul 1, 2024 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 1,140 | $23.43 | $26,710 | — | Jun 27, 2024 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 11,422 | $21.63 | $247,058 | 1,076,103 | Jun 25, 2024 |
| Heyman Richard A. | — | Sale | 1,270 | $21.48 | $27,280 | 134,615 | Jun 17, 2024 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 1,133 | $20.06 | $22,728 | — | Jun 6, 2024 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 2,123 | $22.52 | $47,810 | — | May 29, 2024 |